Small intestinal thrombotic microangiopathy following kidney transplantation diagnosed by balloon-assisted enteroscopy

Thrombotic microangiopathy (TMA) is a serious complication following kidney transplantation. Although intestinal TMA is a major organ injury and causes abdominal pain, diarrhea and bloody stools, the clinical and endoscopic characteristics of small intestinal TMA remain unclear. Here, we report a drug-induced small intestinal TMA, which did not meet the laboratory-defined TMA criteria but was diagnosed by balloon-assisted enteroscopy (BAE). A 32-year-old woman who underwent kidney transplantation at the age of 10 years complained of abdominal pain, diarrhea and bloody stools one month after starting everolimus (EVE) as an immunosuppressant. Although she did not meet the diagnostic criteria for TMA serologically, BAE revealed a circumferential ulcer in the jejunum, and the pathological findings of a biopsy specimen showed microvascular thrombi, compatible with intestinal TMA. Her symptoms improved upon the discontinuation of EVE, demonstrating that EVE can cause drug-induced intestinal TMA. The present case suggests that BAE should be performed when abdominal pain, diarrhea, and bloody stools occur in patients receiving immunosuppressive medication following kidney transplantation, even if there is no evidence of TMA according to the laboratory definition.

[1]  B. Buchholz,et al.  Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome – a case report , 2020, BMC Nephrology.

[2]  K. Friedman,et al.  Impact of treatment and outcomes for patients with posttransplant drug‐associated thrombotic microangiopathy , 2017, Transfusion.

[3]  Y. Kodera,et al.  Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy , 2009, Bone Marrow Transplantation.

[4]  Y. Kanda,et al.  Intestinal thrombotic microangiopathy following reduced-intensity umbilical cord blood transplantation , 2005, Bone Marrow Transplantation.

[5]  F. Madoré,et al.  Increased Risk of Thrombotic Microangiopathy in Patients Receiving a Cyclosporin–Sirolimus Combination , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  Y. Kodera,et al.  Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease , 2004, Bone Marrow Transplantation.

[7]  D. Goldsmith,et al.  Thrombotic Micro‐Angiopathy with Sirolimus‐Based Immunosuppression: Potentiation of Calcineurin‐Inhibitor‐Induced Endothelial Damage? , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  H. Rennke,et al.  De novo thrombotic microangiopathy after kidney transplantation. , 2018, Transplantation reviews.

[9]  J. Moake,et al.  Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. , 2007, Haematologica.